Home » Market News

Bombardier, Inc. Class B (TSE:BBD.B) Receives Consensus Rating of “Hold” from Analysts

Bombardier, Inc. Class B (TSE:BBD.B) Receives Consensus Rating of “Hold” from Analysts

Bombardier, Inc. Class B (TSE:BBD.B – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eleven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the... More of this article »
Huntington Bancshares Incorporated (NASDAQ:HBAN) Receives Average Rating of “Moderate Buy” from Analysts

Huntington Bancshares Incorporated (NASDAQ:HBAN) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Huntington Bancshares Incorporated (NASDAQ:HBAN – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty research firms that are covering the firm, MarketBeat.com reports. One... More of this article »
Illumina, Inc. (NASDAQ:ILMN) Given Average Rating of “Hold” by Analysts

Illumina, Inc. (NASDAQ:ILMN) Given Average Rating of “Hold” by Analysts

Shares of Illumina, Inc. (NASDAQ:ILMN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nineteen brokerages that are presently covering the firm, Marketbeat.com reports. Two equities... More of this article »
Aon plc (NYSE:AON) Receives Average Rating of “Moderate Buy” from Analysts

Aon plc (NYSE:AON) Receives Average Rating of “Moderate Buy” from Analysts

Aon plc (NYSE:AON – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seventeen ratings firms that are currently covering the stock, Marketbeat.com reports. Four analysts have... More of this article »
V2X, Inc. (NYSE:VVX) Given Average Rating of “Moderate Buy” by Brokerages

V2X, Inc. (NYSE:VVX) Given Average Rating of “Moderate Buy” by Brokerages

Shares of V2X, Inc. (NYSE:VVX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the thirteen analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the... More of this article »
Weekly Investment Analysts’ Ratings Updates for Glaukos (GKOS)

Weekly Investment Analysts’ Ratings Updates for Glaukos (GKOS)

Glaukos (NYSE: GKOS) recently received a number of ratings updates from brokerages and research firms: 6/21/2026 – Glaukos was downgraded by Wall Street Zen from “buy” to “hold”. 6/17/2026 – Glaukos... More of this article »
Evergy Inc. (NASDAQ:EVRG) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Evergy Inc. (NASDAQ:EVRG) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Evergy Inc. (NASDAQ:EVRG – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the company, Marketbeat reports. Three... More of this article »
Melco Resorts & Entertainment Limited (NASDAQ:MLCO) Receives Consensus Recommendation of “Hold” from Brokerages

Melco Resorts & Entertainment Limited (NASDAQ:MLCO) Receives Consensus Recommendation of “Hold” from Brokerages

Melco Resorts & Entertainment Limited (NASDAQ:MLCO – Get Free Report) has been assigned a consensus rating of “Hold” from the ten analysts that are currently covering the firm, MarketBeat Ratings reports. Two... More of this article »
Aviva PLC (OTCMKTS:AVVIY) Receives Average Recommendation of “Moderate Buy” from Analysts

Aviva PLC (OTCMKTS:AVVIY) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Aviva PLC (OTCMKTS:AVVIY – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat.com reports. Three investment analysts... More of this article »
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Given Average Recommendation of “Moderate Buy” by Analysts

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Given Average Recommendation of “Moderate Buy” by Analysts

Capricor Therapeutics, Inc. (NASDAQ:CAPR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten brokerages that are covering the company, MarketBeat Ratings reports. One investment... More of this article »
Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of “Moderate Buy” from Analysts

Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of “Moderate Buy” from Analysts

Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen brokerages that are currently covering the company, Marketbeat.com reports. One analyst has... More of this article »
CNX Resources Corporation. (NYSE:CNX) Given Average Recommendation of “Reduce” by Analysts

CNX Resources Corporation. (NYSE:CNX) Given Average Recommendation of “Reduce” by Analysts

CNX Resources Corporation. (NYSE:CNX – Get Free Report) has earned an average recommendation of “Reduce” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. Four research... More of this article »
Ameris Bancorp (NASDAQ:ABCB) Receives Average Recommendation of “Moderate Buy” from Analysts

Ameris Bancorp (NASDAQ:ABCB) Receives Average Recommendation of “Moderate Buy” from Analysts

Ameris Bancorp (NASDAQ:ABCB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts... More of this article »
SLR Investment Corp. (NASDAQ:SLRC) Receives Average Recommendation of “Reduce” from Analysts

SLR Investment Corp. (NASDAQ:SLRC) Receives Average Recommendation of “Reduce” from Analysts

Shares of SLR Investment Corp. (NASDAQ:SLRC – Get Free Report) have been assigned an average recommendation of “Reduce” from the seven ratings firms that are presently covering the company, Marketbeat Ratings reports.... More of this article »
Pilgrim’s Pride Corporation (NASDAQ:PPC) Given Average Rating of “Hold” by Brokerages

Pilgrim’s Pride Corporation (NASDAQ:PPC) Given Average Rating of “Hold” by Brokerages

Shares of Pilgrim’s Pride Corporation (NASDAQ:PPC – Get Free Report) have earned an average recommendation of “Hold” from the seven research firms that are currently covering the company, Marketbeat reports.... More of this article »
American Well Corporation (NYSE:AMWL) Given Consensus Rating of “Hold” by Brokerages

American Well Corporation (NYSE:AMWL) Given Consensus Rating of “Hold” by Brokerages

Shares of American Well Corporation (NYSE:AMWL – Get Free Report) have been assigned an average rating of “Hold” from the five brokerages that are covering the company, Marketbeat Ratings reports. One investment... More of this article »
BE Semiconductor Industries NV (OTCMKTS:BESIY) Given Average Recommendation of “Moderate Buy” by Analysts

BE Semiconductor Industries NV (OTCMKTS:BESIY) Given Average Recommendation of “Moderate Buy” by Analysts

BE Semiconductor Industries NV (OTCMKTS:BESIY – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, Marketbeat Ratings reports. Four... More of this article »
SharkNinja, Inc. (NYSE:SN) Given Consensus Rating of “Moderate Buy” by Analysts

SharkNinja, Inc. (NYSE:SN) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of SharkNinja, Inc. (NYSE:SN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are presently covering the stock, Marketbeat.com reports. Two research... More of this article »
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of “Buy” from Analysts

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of “Buy” from Analysts

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received a consensus recommendation of “Buy” from the fourteen brokerages that are covering the firm, MarketBeat.com reports. One research analyst ... More of this article »
SoundHound AI, Inc. (NASDAQ:SOUN) Given Average Rating of “Moderate Buy” by Brokerages

SoundHound AI, Inc. (NASDAQ:SOUN) Given Average Rating of “Moderate Buy” by Brokerages

Shares of SoundHound AI, Inc. (NASDAQ:SOUN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the stock, Marketbeat reports. One equities... More of this article »
StandardAero, Inc. (NYSE:SARO) Receives Consensus Recommendation of “Moderate Buy” from Analysts

StandardAero, Inc. (NYSE:SARO) Receives Consensus Recommendation of “Moderate Buy” from Analysts

StandardAero, Inc. (NYSE:SARO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fourteen analysts that are covering the firm, Marketbeat.com reports. Six equities research analysts... More of this article »
Safehold Inc. (NYSE:SAFE) Given Average Recommendation of “Hold” by Brokerages

Safehold Inc. (NYSE:SAFE) Given Average Recommendation of “Hold” by Brokerages

Safehold Inc. (NYSE:SAFE – Get Free Report) has received an average recommendation of “Hold” from the eleven analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have... More of this article »
LGI Homes, Inc. (NASDAQ:LGIH) Receives Average Rating of “Hold” from Analysts

LGI Homes, Inc. (NASDAQ:LGIH) Receives Average Rating of “Hold” from Analysts

Shares of LGI Homes, Inc. (NASDAQ:LGIH – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Two equities... More of this article »
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Average Rating of “Hold” by Analysts

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Average Rating of “Hold” by Analysts

Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) have received an average recommendation of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat.com reports. Two... More of this article »
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Consensus Recommendation of “Moderate Buy” by Analysts

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, MarketBeat.com reports.... More of this article »